Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000594619 | SCV000704897 | uncertain significance | not provided | 2017-01-13 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000622748 | SCV000742017 | uncertain significance | Inborn genetic diseases | 2016-12-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000707123 | SCV000836206 | uncertain significance | Epilepsy, X-linked 1, with variable learning disabilities and behavior disorders | 2024-10-20 | criteria provided, single submitter | clinical testing | This sequence change replaces threonine, which is neutral and polar, with isoleucine, which is neutral and non-polar, at codon 124 of the SYN1 protein (p.Thr124Ile). This variant is present in population databases (no rsID available, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with SYN1-related conditions. ClinVar contains an entry for this variant (Variation ID: 499415). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |